Top Markets
Coin of the day
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)

Xvivo Perfusion AB (publ)

XVIVO
Pozycja w akcjach #9727
Xvivo Perfusion AB (publ) is a medical technology company that creates and... Xvivo Perfusion AB (publ) is a medical technology company that creates and supplies advanced solutions for the preservation and perfusion of organs, tissues, and cells, primarily for use in transplantation. The company's global reach extends across Sweden, the United States, both North and South America, Europe, the Middle East, Africa, and the Asia Pacific region. Its product line includes the XVIVO System (XPS), an integrated, ready-to-use cardiac bypass system designed to facilitate safe normothermic ex vivo lung perfusion (EVLP). To support this, the XPS Disposable Lung Kit offers all the necessary sterile, pre-packed components for EVLP procedures. Xvivo also provides STEEN Solution, an optimally formulated buffered extracellular solution specifically for perfusing isolated donor lungs during EVLP. Additional offerings comprise Perfadex Plus, an extracellular, low-potassium, dextran-based electrolyte preservation solution, and the XVIVO Silicone Tubing Set, used for efficient flushing of donor lungs during the procurement process. The company also manufactures the XVIVO LS and XVIVO Disposable Lung Set, both critical devices for EVLP. Furthermore, Xvivo provides the XVIVO Organ Chamber, a sterile, single-use disposable container for temporarily housing isolated lungs before transplantation, and the XVIVO Lung Cannula Set, another sterile, single-use disposable medical product. Established in 1998, Xvivo Perfusion AB (publ) is headquartered in Gothenburg, Sweden.
Cena akcji
$30.43
Ostatnia synchronizacja: 2026-08-28
Kapitalizacja rynkowa
$958.38M
Zmiana (1 dzień)
-3.95%
Zmiana (1 rok)
71.66%
Kraj
SE
Handel Xvivo Perfusion AB (publ) (XVIVO)

Kategoria

Cena XVIVO z kapitalizacją rynkową B
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
XVIVO
$30.43
Kapitalizacja rynkowa Xvivo Perfusion AB (publ)(XVIVO)
Kapitalizacja rynkowa: $958.38M
Na dzień August 2026 spółka Xvivo Perfusion AB (publ) ma kapitalizację rynkową wynoszącą $958.38M. Według naszych danych, czyni to Xvivo Perfusion AB (publ) 9727th najcenniejszą firmą na świecie pod względem kapitalizacji rynkowej. Kapitalizacja rynkowa to całkowita wartość rynkowa wszystkich wyemitowanych akcji spółki giełdowej i jest powszechnie stosowana do oceny jej wartości.
Historia kapitalizacji rynkowej Xvivo Perfusion AB (publ) od 2012 do 2026
XVIVO w porównaniu do 5 najpopularniejszych stocks
Cena za XVIVO Aktywa B Kapitalizacja rynkowa B Wyniki
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$167,110 $958.38M
$5.264T +549,145.58%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$149,249 $958.38M
$4.701T +490,443.29%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$132,611 $958.38M
$4.177T +435,757.53%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$121,189 $958.38M
$3.817T +398,217.51%
Xvivo Perfusion AB (publ) Xvivo Perfusion AB (publ)
$90,996.35 $958.38M
$2.866T +298,981.00%